Irene Kuter
0000-0002-6422-8894
1 paper found
Refreshing results…
A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer
Missing publications? Search for publications with a matching author name.